These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 17450147)

  • 1. Ligand interaction scan: a general method for engineering ligand-sensitive protein alleles.
    Erster O; Eisenstein M; Liscovitch M
    Nat Methods; 2007 May; 4(5):393-5. PubMed ID: 17450147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A modified inverse PCR procedure for insertion, deletion, or replacement of a DNA fragment in a target sequence and its application in the ligand interaction scan method for generation of ligand-regulated proteins.
    Erster O; Liscovitch M
    Methods Mol Biol; 2010; 634():157-74. PubMed ID: 20676983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid and easy development of versatile tools to study protein/ligand interactions.
    Vandevenne M; Gaspard G; Yilmaz N; Giannotta F; Frère JM; Galleni M; Filée P
    Protein Eng Des Sel; 2008 Jul; 21(7):443-51. PubMed ID: 18456870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered inhibitor sensitivity in the WPD loop of a protein tyrosine phosphatase.
    Zhang XY; Bishop AC
    Biochemistry; 2008 Apr; 47(15):4491-500. PubMed ID: 18358001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein evolution by codon-based random deletions.
    Osuna J; Yáñez J; Soberón X; Gaytán P
    Nucleic Acids Res; 2004 Sep; 32(17):e136. PubMed ID: 15459282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creating small-molecule-dependent switches to modulate biological functions.
    Buskirk AR; Liu DR
    Chem Biol; 2005 Feb; 12(2):151-61. PubMed ID: 15734643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering switches, genetically.
    Roberts RW
    Chem Biol; 2004 Nov; 11(11):1475-6. PubMed ID: 15555994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammalian cell-based optimization of the biarsenical-binding tetracysteine motif for improved fluorescence and affinity.
    Martin BR; Giepmans BN; Adams SR; Tsien RY
    Nat Biotechnol; 2005 Oct; 23(10):1308-14. PubMed ID: 16155565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tying up the loose ends: circular permutation decreases the proteolytic susceptibility of recombinant proteins.
    Whitehead TA; Bergeron LM; Clark DS
    Protein Eng Des Sel; 2009 Oct; 22(10):607-13. PubMed ID: 19622546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of effector affinity by hinge region mutations also modulates switching activity in an engineered allosteric TEM1 beta-lactamase switch.
    Kim JR; Ostermeier M
    Arch Biochem Biophys; 2006 Feb; 446(1):44-51. PubMed ID: 16384549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of tetracysteine-tagged proteins by affinity chromatography using a non-fluorescent, photochemically stable bisarsenical affinity ligand.
    Ying LQ; Branchaud BP
    Bioconjug Chem; 2011 May; 22(5):987-92. PubMed ID: 21480579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creating hybrid proteins by insertion of exogenous peptides into permissive sites of a class A beta-lactamase.
    Ruth N; Quinting B; Mainil J; Hallet B; Frère JM; Huygen K; Galleni M
    FEBS J; 2008 Oct; 275(20):5150-60. PubMed ID: 18793326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative binding proteins: anticalins - harnessing the structural plasticity of the lipocalin ligand pocket to engineer novel binding activities.
    Skerra A
    FEBS J; 2008 Jun; 275(11):2677-83. PubMed ID: 18435758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAISE: a simple and novel method of generating random insertion and deletion mutations.
    Fujii R; Kitaoka M; Hayashi K
    Nucleic Acids Res; 2006; 34(4):e30. PubMed ID: 16493137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A chemical genetic method for generating bivalent inhibitors of protein kinases.
    Hill ZB; Perera BG; Maly DJ
    J Am Chem Soc; 2009 May; 131(19):6686-8. PubMed ID: 19391594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Covalent labelling of fusion proteins in live cells via an engineered receptor-ligand pair.
    Krusemark CJ; Belshaw PJ
    Org Biomol Chem; 2007 Jul; 5(14):2201-4. PubMed ID: 17609747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A general approach for developing system-specific functions to score protein-ligand docked complexes using support vector inductive logic programming.
    Amini A; Shrimpton PJ; Muggleton SH; Sternberg MJ
    Proteins; 2007 Dec; 69(4):823-31. PubMed ID: 17910057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering the glycosaminoglycan-binding affinity, kinetics and oligomerization behavior of RANTES: a tool for generating chemokine-based glycosaminoglycan antagonists.
    Brandner B; Rek A; Diedrichs-Möhring M; Wildner G; Kungl AJ
    Protein Eng Des Sel; 2009 Jun; 22(6):367-73. PubMed ID: 19414521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased folding stability of TEM-1 beta-lactamase by in vitro selection.
    Kather I; Jakob RP; Dobbek H; Schmid FX
    J Mol Biol; 2008 Oct; 383(1):238-51. PubMed ID: 18706424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into positive and negative requirements for protein-protein interactions by crystallographic analysis of the beta-lactamase inhibitory proteins BLIP, BLIP-I, and BLP.
    Gretes M; Lim DC; de Castro L; Jensen SE; Kang SG; Lee KJ; Strynadka NC
    J Mol Biol; 2009 Jun; 389(2):289-305. PubMed ID: 19332077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.